LMR Partners’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Hold |
539,588
| – | – | ﹤0.01% | 727 |
|
|
2025
Q1 | $18.8K | Hold |
539,588
| – | – | ﹤0.01% | 794 |
|
|
2024
Q4 | $40.6K | Buy |
+539,588
| New | +$40.6K | ﹤0.01% | 643 |
|
|
2024
Q3 | – | Sell |
-539,588
| Closed | -$25.6K | – | 869 |
|
|
2024
Q2 | $25.6K | Hold |
539,588
| – | – | ﹤0.01% | 576 |
|
|
2024
Q1 | $21K | Hold |
539,588
| – | – | ﹤0.01% | 611 |
|
|
2023
Q4 | $16.3K | Hold |
539,588
| – | – | ﹤0.01% | 521 |
|
|
2023
Q3 | $37.8K | Hold |
539,588
| – | – | ﹤0.01% | 536 |
|
|
2023
Q2 | $56.3K | Hold |
539,588
| – | – | ﹤0.01% | 533 |
|
|
2023
Q1 | $237K | Hold |
539,588
| – | – | ﹤0.01% | 822 |
|
|
2022
Q4 | $318K | Buy |
539,588
+152,000
| +39% | +$89.7K | 0.01% | 933 |
|
|
2022
Q3 | $272K | Buy |
387,588
+29,239
| +8% | +$20.5K | 0.01% | 960 |
|
|
2022
Q2 | $520K | Buy |
358,349
+21,067
| +6% | +$30.6K | 0.01% | 895 |
|
|
2022
Q1 | $1.27M | Buy |
337,282
+320,982
| +1,969% | +$1.21M | 0.01% | 716 |
|
|
2021
Q4 | $127K | Buy |
+16,300
| New | +$127K | ﹤0.01% | 1095 |
|